Short- to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma

Cancer Biology and Therapy

Volumn 8, Issue 7, 2009, Pages 585-590

  Zhang, Fu Jun ^a   Li, Chuan Xing ^a   Liang, Zhang ^a   Wu, Pei Hong ^a   Jiao, De Chao ^a   Duan, Guang Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

125Iodine seed implantation; Brachytherapy; Hepatocellular carcinoma; Liver transplantation

Indexed keywords

IODINE 125; SORAFENIB;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DRUG TARGETING; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; METASTASIS; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 66149100051     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.7.7902     Document Type: Article

References (30)

1. Marsh JW, Geller DA, Finkelstein SD, Donaldson JB, Dvorchik I. Role of liver transplantation for hepatobiliary malignant disorders. Lancet Oncol 2004; 5:3-6. (Pubitemid 39069398)
2. Tran TT, Nissen N, Poordad FF, Martin P. Advances in liver transplantation. New strategies and current care expand access, enhance survival. Postgrad Med 2004; 115:73-85. (Pubitemid 38623736)
3. Dinckan A, Turkyilmaz S, Tekin A, Duman A, Yilmaz A, Mesci A, et al. Evaluation of the first 100 liver transplantations. Turk J Gastroenterol 2008; 19:28-32.
4. Heimbach JK. Liver transplantation for hepatocellular carcinoma. Cancer 2008; 14:95-99
5. Ryckman FC, Bucuvalas JC, Nathan J, Alonso M, Tiao G, Balistreri WF. Outcomes following liver transplantation. Semin Pediatr Surg 2008; 17:123-130
6. Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Yamashita Y, Maehara Y. Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008; 15:124-130
7. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988; 207:373-379
8. Zheng SS, Xu X, Liang TB, Wang WL, Shen Y, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases. Zhonghua Wai Ke Za Zhi 2005; 43:450-454
9. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47:207-214 (Pubitemid 11167383)
10. Lo CM, Fan ST. Liver transplantation for hepatocellular carcinoma. Br J Surg 2004; 91:131-133 (Pubitemid 38233954)
11. Molmenti EP, Klintmalm GB. Hepatocellular cancer in liver transplantation. J Hepatobiliary Pancreat Surg 2001; 8:427-434 (Pubitemid 33725574)
12. Tan KC. Liver transplantation for hepatocellular carcinoma: how far can we push the envelope? Singapore Med J 2003; 44:309-311
13. Regalia E, Coppa J, Pulvirenti A, Romito R, Schiavo M, Burgoa L, et al. Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transplant Proc 2001; 33:1442-1444 (Pubitemid 32237918)
14. Klintmalm GB. The history of organ transplantation in the Baylor Health Care System. Proc (Bayl Univ Med Cent) 2004; 17:23-34.
15. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699 (Pubitemid 26079803)
16. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10:36-41. (Pubitemid 38885890)
17. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33:1394-1403 (Pubitemid 32496976)
18. Chen Z, He F, Zeng F, Ming C, Jiang J, Du G, et al. Impact of steroid withdrawal on recurrent rate of carcinoma after liver transplantation of hepatocellular carcinoma. Chin J Organ Transpl 2006; 27:156-159
19. Vivarelli M, Bellusci R, Cucchetti A, Cavrini G, De Ruvo N, Aden AA, et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 2002; 74:1746-1751
20. Lee HH, Joh JW, Park JH, Lee KW, Heo JS, Choi SH, et al. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma. Transplant Proc 2005; 37:1251-1253 (Pubitemid 40590853)
21. Perez Saborido B, Loinaz Segurola C, Gimeno Calvo A, Meneu Diaz JC, Abradelo de Usera M, Calvo Pulido J, et al. Liver transplantation for hepatocellular carcinoma: our experience from 1986. Transplant Proc 2003; 35:1825-1826
22. Shao ZX, Xu X, Zheng SS, Liang TB, Ke QH, Ma YP. Serum a-fetoprotein alterations and tumor recurrence after liver transplantation for hepatocellular carcinoma patients. Chin J of General Surgery 2006; 21:351-353
23. Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R, et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004; 78:1780-1786 (Pubitemid 40041645)
24. Little SA, Fong Y. Hepatocellular carcinoma: current surgical management. Semin Oncol 2001; 28:474-486 (Pubitemid 32959594)
25. Pokorny H, Gnant M, Rasoul-Rockenschaub S, Gollackner B, Steiner B, Steger G, et al. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation? Am J Transplant 2005; 5:788-794
26. Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 2006; 24:4293-4300 (Pubitemid 46630787)
27. Johnson M, Colonias A, Parda D, Trombetta M, Gayou O, Reitz B, et al. Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer. Phys Med Biol 2007; 52:1237-1245 (Pubitemid 46646384)
28. Peretz T, Nori D, Hilaris B, Manolatos S, Linares L, Harrison L, et al. Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Int J Radiat Oncol Biol Phys 1989; 17:931-935 (Pubitemid 19279494)
29. 125I implantation in treatment of pancreatic cancer. Zhonghua Yi Xue Za Zhi 2006; 86:223-227
30. Ebara S, Katayama N, Tanimoto R, Edamura K, Nose H, Manabe D, et al. Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer. Acta Med Okayama 2008; 62:9-13.